Mycomax (Fluconazole)

Fluconazole, the active ingredient in Mycomax, is an azole antifungal presented as an oral dosage for systemic use. It treats a range of fungal infections, including candidiasis and cryptococcal disease, in adult and pediatric patients as prescribed by a healthcare professional.

GNH USA supplies Mycomax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Fluconazole acts on fungal infections by inhibiting ergosterol synthesis, making it effective for several Candida and Cryptococcus species.

- Candidiasis: resolves mucosal and systemic Candida infections, including oropharyngeal, esophageal and vaginal forms. - Cryptococcal meningitis: treats systemic cryptococcal infections, particularly in immunocompromised patients. - Prophylaxis in immunocompromised patients: prevents opportunistic fungal infections during chemotherapy or organ transplantation.

Fluconazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Rash: skin erythema or pruritus. - Diarrhea: loose stools, usually self‑limiting. - Abdominal pain: cramping or discomfort. - Taste alteration: dysgeusia or metallic taste.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: acute hypersensitivity with respiratory compromise. - QT prolongation: cardiac rhythm disturbances. - Hepatic failure: rare but life‑threatening liver dysfunction. - Severe liver enzyme elevation: marked transaminase rise requiring monitoring.

Fluconazole should be used with careful clinical assessment and monitoring.

- Liver function monitoring: assess baseline enzymes and repeat during therapy. - Renal impairment adjustment: dose may need modification in severe kidney disease. - Drug interaction vigilance: review concomitant medications for CYP interactions. - Hypersensitivity avoidance: discontinue if allergic reactions occur. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Fluconazole interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may cause toxic fluconazole levels. - QT‑prolonging agents (e.g., cisapride, quinidine): increase risk of cardiac arrhythmia. - Warfarin: potentiates anticoagulant effect, raising INR.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced efficacy, consider alternative contraception. - Antacids containing aluminum or magnesium: may decrease fluconazole absorption. - Rifampin: induces metabolism, lowering fluconazole concentrations. - Statins (e.g., simvastatin): increased risk of myopathy, monitor muscle symptoms. - Phenytoin: may reduce fluconazole levels, adjust dosing if needed.